BioCentury
ARTICLE | Clinical News

Bavituximab: Interim Phase III data

October 17, 2016 7:00 AM UTC

Interim data from the double-blind, international Phase III SUNRISE trial in about 582 previously treated patients with stage IIIb/IV non-squamous NSCLC showed that once-weekly IV bavituximab plus doc...